Literature DB >> 8056941

Measurement of severity in advanced Alzheimer's disease.

L Volicer1, A C Hurley, D C Lathi, N W Kowall.   

Abstract

BACKGROUND: In late stages of dementia of the Alzheimer type (DAT), most scales measuring only cognitive or functional deficits lose their sensitivity to detect further disease progression.
METHODS: By combining ratings of cognitive (speech, eye contact) and functional deficits (dressing, eating, ambulation) with occurrence of pathological symptoms (sleep-wake cycle disturbance, muscle rigidity/contractures), a scale was developed (BANS-S) which does not lose its sensitivity until the patient reaches a vegetative state. BANS-S was tested on three Special Care Dementia Units.
RESULTS: Data from 74 patients with the clinical diagnosis of DAT indicated that BANS-S has good reliability and reproducibility. BANS-S scores correlated with scores of Mini-Mental State Examination, Katz ADL, Test for Severe Impairment, and Language Assessment. In 25 patients with the diagnosis of DAT confirmed by autopsy, BANS-S scores determined within 3 months of death correlated with density of neurofibrillary tangles in CA2 and CA3 areas of the hippocampus.
CONCLUSION: BANS-S may be a useful tool for the evaluation of different treatment strategies in severe DAT and for the correlation of clinical and pathological findings.

Entities:  

Mesh:

Year:  1994        PMID: 8056941     DOI: 10.1093/geronj/49.5.m223

Source DB:  PubMed          Journal:  J Gerontol        ISSN: 0022-1422


  57 in total

1.  Scales for the evaluation of end-of-life care in advanced dementia: sensitivity to change.

Authors:  Dan K Kiely; Michele L Shaffer; Susan L Mitchell
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Oct-Dec       Impact factor: 2.703

2.  Response to Sheehan, B. (2012) Assessment scales in dementia. Ther Adv Neurol Disord 5: 349-358.

Authors:  Ladislav Volicer
Journal:  Ther Adv Neurol Disord       Date:  2013-09       Impact factor: 6.570

3.  Medicare expenditures among nursing home residents with advanced dementia.

Authors:  Keith S Goldfeld; David G Stevenson; Mary Beth Hamel; Susan L Mitchell
Journal:  Arch Intern Med       Date:  2011-01-10

4.  Grief among family members of nursing home residents with advanced dementia.

Authors:  Jane L Givens; Holly G Prigerson; Dan K Kiely; Michele L Shaffer; Susan L Mitchell
Journal:  Am J Geriatr Psychiatry       Date:  2011-06       Impact factor: 4.105

5.  Hospital transfers of nursing home residents with advanced dementia.

Authors:  Jane L Givens; Kevin Selby; Keith S Goldfeld; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2012-03-16       Impact factor: 5.562

6.  Healthcare Proxy Awareness of Suspected Infections in Nursing Home Residents with Advanced Dementia.

Authors:  Jane L Givens; Sara Spinella; Claire K Ankuda; Erika D'Agata; Michele L Shaffer; Daniel Habtemariam; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2015-06-01       Impact factor: 5.562

7.  Preliminary data from an advanced dementia consult service: integrating research, education, and clinical expertise.

Authors:  Angela G Catic; Andrea I Berg; Julie A Moran; Julie R Knopp; Jane L Givens; Dan K Kiely; Nicky Quinlan; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2013-11-01       Impact factor: 5.562

8.  Concordance Between Proxy Level of Care Preference and Advance Directives Among Nursing Home Residents With Advanced Dementia: A Cluster Randomized Clinical Trial.

Authors:  Simon M Cohen; Angelo E Volandes; Michele L Shaffer; Laura C Hanson; Daniel Habtemariam; Susan L Mitchell
Journal:  J Pain Symptom Manage       Date:  2018-09-29       Impact factor: 3.612

9.  Health care proxy grief symptoms before the death of nursing home residents with advanced dementia.

Authors:  Dan K Kiely; Holly Prigerson; Susan L Mitchell
Journal:  Am J Geriatr Psychiatry       Date:  2008-08       Impact factor: 4.105

10.  Survival After Suspected Urinary Tract Infection in Individuals with Advanced Dementia.

Authors:  Alyssa B Dufour; Michele L Shaffer; Erika M C D'Agata; Daniel Habtemariam; Susan L Mitchell
Journal:  J Am Geriatr Soc       Date:  2015-11-28       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.